Pharmabiz

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia: Sunnyvale, California Thu ...
Pharmabiz

Melius MicroBiomics receives Australian Dealings Involving Intentional Release licence as key step toward clinical evaluation

Melius MicroBiomics receives Australian Dealings Involving Intentional Release licence as key step toward clinical evaluation: Vancouver, BC Thursday, March 19, 2026, 18:00 Hrs [I ...
Pharmabiz

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...
Pharmabiz

Axplora plans $60 million investment programme at its Farmabios site in Gropello Cairoli

Axplora plans $60 million investment programme at its Farmabios site in Gropello Cairoli: Germany Thursday, March 19, 2026, 16:00 Hrs [IST] Axplora, a global leader in complex act ...
Pharmabiz

Patients to get new medicines up to six months sooner under new joint MHRA-NICE approval process

Patients to get new medicines up to six months sooner under new joint MHRA-NICE approval process: United Kingdom Thursday, March 19, 2026, 13:00 Hrs [IST] The MHRA and NICE aligne ...
Pharmabiz

Zydus Lifesciences launches Aerolife Mini, to simplify inhaler use for asthma and COPD patients

Zydus Lifesciences launches Aerolife Mini, to simplify inhaler use for asthma and COPD patients: Our Bureau, Mumbai Thursday, March 19, 2026, 13:15 Hrs [IST] Zydus Lifesciences Li ...
Pharmabiz

Global survey reveals pet owners lack awareness of parasite risks and seek clearer prevention advice

Global survey reveals pet owners lack awareness of parasite risks and seek clearer prevention advice: Ingelheim, Germany Thursday, March 19, 2026, 14:00 Hrs [IST] World Parasite A ...
Pharmabiz

Lupin Manufacturing Solutions expands Dabhasa manufacturing facility

Lupin Manufacturing Solutions expands Dabhasa manufacturing facility: Our Bureau, Mumbai Thursday, March 19, 2026, 13:30 Hrs [IST] Lupin Manufacturing Solutions (LMS), a global CR ...
Pharmabiz

US FDA grants Breakthrough Therapy designation to Sanofi’s venglustat for type 3 Gaucher disease

US FDA grants Breakthrough Therapy designation to Sanofi’s venglustat for type 3 Gaucher disease: Paris Sanofi announced that the US Fo ...
Pharmabiz

CCDC & University of Leicester rollout £5 million programme to combat the rising cardiovascular burden among older adults in India

CCDC & University of Leicester rollout £5 million programme to combat the rising cardiovascular burden among older adults in India: Our Bureau, Mumbai Thursday, March 19, 2026, 0 ...
Pharmabiz

Sobi presents positive results from EMBRACE phase 2a study of emapalumab in interferon-gamma-driven sepsis at ISICEM

Sobi presents positive results from EMBRACE phase 2a study of emapalumab in interferon-gamma-driven sepsis at ISICEM: Stockholm Thursday, March 19, 2026, 12:00 Hrs [IST] Sobi, a g ...
Pharmabiz

Samsung Bioepis inks partnership agreement with Sandoz for up to five next-generation biosimilar candidates

Samsung Bioepis inks partnership agreement with Sandoz for up to five next-generation biosimilar candidates: Incheon, Korea Thursday, March 19, 2026, 11:00 Hrs [IST] Samsung Bioep ...